Resources available through this program:

  • Arranging Follow-Up and Providing Support
    For patients who agree to quit smoking or for whom you prescribe therapy, follow-up is extremely important. Ideally, the steps toward cessation should proceed as follows in this resource.
  • Assess the Patient's Motivation: Readiness to Change
    People tend to pass through different stages in the process of changing (Prochaska and DiClemente 1982; Prochaska and Velicer 1997). The stages are as follows:
  • Avoiding Triggers
    Situations in which patients may find they desire to smoke. Includes possible solutions to these situations.
  • Brief Negotiation Interview
    The following describes the Brief Negotiation Interview:
  • Bupropion Hydrochloride SR (Zyban®)
    See FDA insert for more information
  • Change Plan Worksheet
    This change plan worksheet can be given to patients for them to outline their treatment goals.
  • Cigarette Smoking and Cardiovascular Diseases
    Cigarette smoking is the most important preventable cause of premature death in the United States. It accounts for more than 440,000 of the more than 2.4 million annual deaths. Cigarette smokers have a higher risk of developing several chronic disorders. These include fatty buildups in arteries, several types of cancer and chronic obstructive pulmonary disease (lung problems). Atherosclerosis (buildup of fatty substances in the arteries) is a chief contributor to the high number of deaths from smoking. Many studies detail the evidence that cigarette smoking is a major cause of coronary heart disease, which leads to heart attack. (From Their Website)
  • Clinical Practice Guideline: Treating Tobacco Use and Dependence
    Treating Tobacco Use and Dependence: 2008 Update includes new, effective clinical treatments for tobacco dependence and the latest information to help people quit smoking. (From Their Website)
  • Fagerström Test for Nicotine Dependence
    Fagerström Test for Nicotine Dependence from Heatherton et al., 1991
  • Fagerström Test for Nicotine Dependence: John's Results
    The following are the results of the Faegerström Test for Nicotine Dependence for patient John:
  • FDA-Approved Pharmacotherapy for Tobacco Dependence
    A chart giving information on different products for tobacco dependence including the nicotine patch, gum, lozenge, nazal spray, bupropion, and varenicline.
  • FDA Drug Safety Communication: FDA revises description of mental health side effects of the stop-smoking medicines Chantix (varenicline) and Zyban (bupropion) to reflect clinical trial findings
    This public health advisory, issued by the FDA in 2016, warns about the possibility of severe changes in mood and behavior in patients taking Chantix and Zyban.
  • Handout: Cost of Nicotine Replacement Therapy During Initial Treatment Phase
    The following table compares the approximate costs for Nicotine Replacement Therapy (NRT) for a moderate smoker (1.5 packs per day) during the initial treatment phase (6 weeks) when the full dose of medications are used.
  • Handout: Cost per Day of First-Line Pharmacotherapies
    The following table lists the cost per day of various first-line pharmacotherapies for tobacco cessation. The initial price of each treatment may seem high, but it is much less if the cost of smoking is subtracted. A higher long-term price is paid for the continued use of cigarettes.
  • Handout: Patient Needs Influence Drug Selection
    This table lists patient needs/characteristics that need to considered when determining which smoking cessation medication is optimal.
  • Lung Cancer Risk Assessment
    This prediction tool can assess a long-term smoker's risk of developing lung cancer in the next 10 years based on the person's age, sex, smoking history, and asbestos exposure. Knowing about risk can help clinicians and patients make decisions about health care, such as whether to get screened for lung cancer. (From Their Website)
  • Medline Plus Drug Information: Bupropion
    Medline Plus' current drug info on bupropion.
  • Medline Plus Drug Information: Varenicline
    Medline Plus' current version of their drug information on Varenicline
  • Monograph 9 -- Cigars: Health Effects and Trends
    Monograph 9 -- Cigars: Health Effects and Trends
  • Motivational Interviewing
    This web page is dedicated to motivational interviewing training. It contains links to a variety of articles, addressing all areas of MI from brief overviews to history, philosophy, principles, working with resistance, interaction techniques, and strategies. The site has a library, training information, and special populations information.
  • Negative Effects of Smoking
    Details the negative effects of smoking.
  • Nicotine Anonymous
    Nicotine Anonymous is a Non-Profit 12 Step Fellowship of men and women helping each other live nicotine-free lives. Nicotine Anonymous welcomes all those seeking freedom from nicotine addiction, including those using cessation programs and nicotine withdrawal aids. The primary purpose of Nicotine Anonymous is to help all those who would like to cease using tobacco and nicotine products in any form. The Fellowship offers group support and recovery using the 12 Steps as adapted from Alcoholics Anonymous to achieve abstinence from nicotine. (From their website)
  • Nicotine Gum
    See FDA package insert for more complete information
  • Nicotine Inhaler
    See FDA package insert for more complete information
  • Nicotine Lozenge.
    See FDA package insert for more complete information.
  • Nicotine Nasal Spray
    See FDA package insert for more complete information
  • Nicotine Patch
    See FDA package insert for more complete information
  • Outside Social Support
    Social support systems outside the clinical setting, such as support groups, are effective in helping patients quit smoking. Some possible components of social support are included in this resource.
  • Patient Handout: Basics of Nicotine
    Patient handout with information on the basics of nicotine.
  • Patient Handout: Bupropion Hydrochloride SR (Zyban®)
    See FDA package insert for more complete information
  • Patient Handout: Health Changes Once You Quit Smoking
    Handout describes the lasting health improvements that result from quitting smoking.
  • Patient Handout: Physical Activity
    Details how ex-smokers are successful at quitting by getting involved in some kind of regular physical activity.
  • Patient Handout: Varenicline (Chantix®)
    See FDA package insert for more complete information.
  • Patient Handout: Why Quit?
    General facts about smoking in regards to special topics like smoking and women, secondhand smoke, and addiction in general.
  • Problem Solving
    Description of problem-solving treatment components, as well as examples. This resource points out how patients can avoid potentially risky situations.
  • Provide Social Support
    A supportive clinical environment is effective in helping patients quit smoking. Encouragement and support from clinical staff is crucial. This resource details supportive treatment and examples.
    Launched in 1995, QuitNet is the Web's original quit smoking site. (From their website)
  • Quit Smoking Support
    Comprehensive information on smoking information, support, and advice for a patient's desire to quit smoking.
  • Quitting Smoking
    Tobacco use is the most common preventable cause of death. About half of the people who don't quit smoking will die of smoking-related problems. Quitting smoking is important for your health and provides many benefits. Soon after you quit, your circulation begins to improve, and your blood pressure starts to return to normal. Your sense of smell and taste return and breathing starts to become easier. In the long term, giving up tobacco can help you live longer. Your risk of getting cancer decreases with each year you stay smoke-free.
  • Quitting Tobacco Use is a Process
    Stages of Quitting
  • Reasons Why Different People Might Want to Quit
    Reasons why different people might want to quit tobacco: symptomatic adults, asymptomatic results, people with family history of cancer or heart disease, long-term users, new users, parents, women, pregnant women, teenagers, and any users.
  • Relapse Handout
    Questions and situations that surround relapse in tobacco cessation.
  • Relapse Prevention
    Describes working to prevent relapse.
  • Setting a Quit Date
    Tips for setting a quit date for tobacco products.
  • ( provides free, accurate, evidence-based information and professional assistance to help support the immediate and long-term needs of people trying to quit smoking.
  • Smoking and Tobacco Use: Quit Smoking
    Learn more about quitting successfully from the resources provided on this page: Benefits of Quitting, Nicotine Addiction, Using Proven Treatments Can Double Your Chance of Success, Five Keys for Quitting Smoking, Special Situations or Conditions, Questions to Think About, and Additional Quit Resources.
  • Smoking Cessation Cycle
    Smoking Cessation Cycle as referenced by Prochaska et al. 1992, 1993; Prochaska and DiClemente 1982
  • The 4 D's: Steps for Coping With Withdrawal
    Details withdrawal symptoms from tobacco cessation and how to manage them.
  • The 5 R's of Motivation
    Details how to increase a patient's motivation to quit using tobacco products.
  • The Health Consequences of Smoking: A Report of the Surgeon General
    The Health Consequences of Smoking: A Report of the Surgeon General
  • Tobacco and Cancer
    A list of articles from the American Cancer Society
  • Tobacco Cessation
    From the American Academy of Family Physicians
    The Foundation for a Smokefree America was founded in 1989 by Patrick Reynolds, a grandson of the founder of the R.J. Reynolds Tobacco Company. A former pack-a-day smoker, Patrick saw his father, oldest brother and other relatives die from cigarette-induced emphysema, heart disease and cancer. (From their website)
  • Tobacco Information and Prevention Source (TIPS)
    A list of informational documents from the CDC
  • Tobacco Use Among U.S. Racial/Ethnic Minority Groups: A Report of the Surgeon General, 1998
    Tobacco Use Among U.S. Racial/Ethnic Minority Groups: A Report of the Surgeon General, 1998
  • Tobacco Use Assessment Form
    Tobacco use assessment form reproduced with modifications from Glynn and Manley, 1998.
  • Treating Tobacco Dependence: Review of the Best and Latest Treatment Options
    A review of the pharmacologic approaches to tobacco cessation.
  • Treating Tobacco Use and Dependence: 2008 Update
    Treating Tobacco Use and Dependence: 2008 Update, sponsored by the Public Health Service, includes new, effective clinical treatments for tobacco dependence that have become available since the 2000 Guideline was published. This update will make an important contribution to the quality of care in the United States and to the health of the American people. (From Their Website)
  • Varenicline (Chantix®)
    For more complete information, and especially because of the warnings associated with this medication, please refer to the FDA package insert before prescribing for full details and up to date information. suicidal thoughts or actions; new or worsening depression, anxiety, or panic attacks; agitation; restlessness; angry or violent behavior; acting dangerously; mania (frenzied, abnormally excited mood or talking); abnormal thoughts or sensations; hallucinations (seeing things or hearing voices that do not exist); feeling that people are against you; feeling confused; or any other sudden or unusual changes in behavior, thinking, or mood.
  • Weight Gain
    Weight gain, for most ex-smokers, can be avoided or controlled. This resource helps patients plan ahead.
  • What are the types of nicotine replacement therapy?
    Contains information on different forms of nicotine replacement therapy, such as the nicotine patch, gum, lozenge, inhalers, and nasal sprays.